Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
479
-
Total 13F shares, excl. options
-
198M
-
Shares change
-
+3.85M
-
Total reported value, excl. options
-
$18.7B
-
Value change
-
+$263M
-
Put/Call ratio
-
1.32
-
Number of buys
-
232
-
Number of sells
-
-239
-
Price
-
$94.71
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q4 2017
603 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q4 2017.
INCYTE CORP - COMMON STOCK (INCY) has 479 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 198M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (34.2M shares), Vanguard Group Inc (18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (14.8M shares), BlackRock Inc. (14.3M shares), WELLINGTON MANAGEMENT GROUP LLP (13.5M shares), SANDS CAPITAL MANAGEMENT, LLC (8.19M shares), STATE STREET CORP (7.56M shares), Capital International Investors (7.21M shares), Capital World Investors (6.12M shares), and BB BIOTECH AG (3.7M shares).
This table shows the top 479 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.